Observational analysis reveals higher cerebrovascular reactivity impairment volumes in symptomatic moyamoya patients, suggesting treatment opportunities.
Motivation: Quantitation of cerebrovascular reactivity (CVR) impairment from hypercapnic MRI stimuli is complicated by differences in imaging parameters, stimuli, and vendors. Goal(s): To evaluate if the volume of CVR impairment represents a reactivity penumbra that correlates directly with recent ischemic symptoms. Approach: Time-regression cerebrovascular reactivity analyses and subsequent area-under-the-curve analyses were applied separately in brain hemispheres of 91 moyamoya participants with versus without focal neurological symptoms in the past six months. Results: The parenchymal volumes of impaired reactivity were significantly higher in the flow territory of ischemic symptoms than in asymptomatic hemispheres. Impact: Cerebrovascular reactivity (CVR) metrics, assessed from fixed-inspired hypercapnic stimuli, differ in brain hemispheres with versus without recent ischemic symptoms; furthermore, the volume of CVR impairment, relative to asymptomatic hemispheres, and the CVR measurements themselves are related to recent ischemic symptomatology.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: